Net profit of Hyphens Pharma International Limited FY 2016-2022
In financial year 2022, Hyphens Pharma International Limited reported a net profit of around 11.4 million Singapore dollars, an increase compared to the previous financial year. Hyphen Pharma International is a Singapore-based specialty pharmaceutical and consumer healthcare group operating in Southeast Asian countries.